Oncology Medical News about hepatocellular carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications
Expert Review of Anticancer Therapy, 10/26/09

Fatourou EM et al. – Certain therapeutic strategies, including radiofrequency ablation and chemoembolization, can enhance the release and exposure of tumor antigens, which might help to overcome the immune tolerance towards the tumor. Therefore, such immune–stimulating therapeutic interventions in combination with immunotherapy strategies represent a promising future approach for HCC treatment.

<< Previous
Circulating Mesothelin Protein and Cellular Antimesothelin...

Next >>
Scrub typhus induced by peripheral blood stem cell...

Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09 Relevance Score: 69%

Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09 Relevance Score: 69%

Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09 Relevance Score: 68%

Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09 Relevance Score: 68%

MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09 Relevance Score: 68%